Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.40 -0.31 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Madrigal Pharmaceuticals' Return on Capital Employed [ROCE] came in at -37.44% for Q2 2026, up 0.84 percentage points from -38.27% a year earlier but down 2.80 percentage points from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Madrigal Pharmaceuticals' Return on Capital Employed [ROCE] was -35.70%, up 38.38 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased in each of the last three years, with a five-year change of +29.30 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -74.08% in FY2024 (+25.27 pp), -99.34% in FY2023 (+45.95 pp), -145.29% in FY2022 (-26.03 pp) and -119.26% in FY2021 (-54.26 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -307.99% (Q3 2022) to -29.99% (Q4 2025).
  • Year-over-year, Return on Capital Employed [ROCE] has increased for 14 consecutive quarters, with an average year-over-year change of +37.27 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2024 (a gain of 144.10 percentage points), and the weakest in Q3 2022 (a drop of 211.86 percentage points).
  • Business Quant data shows MDGL's Return on Capital Employed [ROCE] at -34.63% (Q1 2026), -29.99% (Q4 2025) and -38.56% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Madrigal Pharmaceuticals 14.56 Bn 10.82 Bn - -37.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.44%
Mar 31, 2026 -34.63%
Dec 31, 2025 -29.99%
Sep 30, 2025 -38.56%
Jun 30, 2025 -38.27%
Mar 31, 2025 -49.89%
Dec 31, 2024 -56.04%
Sep 30, 2024 -60.31%
Jun 30, 2024 -54.90%
Mar 31, 2024 -60.80%
Dec 31, 2023 -118.64%
Sep 30, 2023 -204.41%
Jun 30, 2023 -151.78%
Mar 31, 2023 -126.15%
Dec 31, 2022 -202.86%
Sep 30, 2022 -307.99%
Jun 30, 2022 -188.63%
Mar 31, 2022 -144.19%
Dec 31, 2021 -114.28%
Sep 30, 2021 -96.13%
API Access

Madrigal Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MDGL&period=max&api_key=YOUR_API_KEY